FOLD FY 2017 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$37M+644.9% YoY

Gross Profit

$31M83.1% margin

Operating Income

-$442M-1196.8% margin

Net Income

-$284M-769.0% margin

EPS (Diluted)

$-1.85

Cash Flow

Operating Cash Flow

-$215M

Free Cash Flow

-$220M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$627M

Total Liabilities

$274M

Stockholders' Equity

$353M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$5M	+644.9%
Gross Profit	$31M	$4M	+644.1%
Operating Income	-$442M	-$182M	-143.0%
Net Income	-$284M	-$200M	-42.0%